BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15223930)

  • 1. Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis.
    Grauer JN; Vaccaro AR; Kato M; Kwon BK; Beiner JM; Patel TC; Hilibrand AS; Chiba K; Albert TJ
    Spine (Phila Pa 1976); 2004 Jul; 29(13):1405-12. PubMed ID: 15223930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion.
    Patel TC; Erulkar JS; Grauer JN; Troiano NW; Panjabi MM; Friedlaender GE
    Spine (Phila Pa 1976); 2001 Aug; 26(15):1656-61. PubMed ID: 11474350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion.
    Grauer JN; Patel TC; Erulkar JS; Troiano NW; Panjabi MM; Friedlaender GE
    Spine (Phila Pa 1976); 2001 Jan; 26(2):127-33. PubMed ID: 11154530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract.
    Silcox DH; Boden SD; Schimandle JH; Johnson P; Whitesides TE; Hutton WC
    Spine (Phila Pa 1976); 1998 Feb; 23(3):291-6; discussion 297. PubMed ID: 9507615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic protein-1 induced gene expression: evaluation in a posterolateral spinal pseudarthrosis model.
    White AP; Maak TG; Prince D; Vaccaro AR; Albert TJ; Hilibrand AS; Grauer JN
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2550-5. PubMed ID: 17047543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.
    Vaccaro AR; Anderson DG; Patel T; Fischgrund J; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2005 Dec; 30(24):2709-16. PubMed ID: 16371892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2004 Sep; 29(17):1885-92. PubMed ID: 15534410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of osteogenic protein-1 in instrumented and noninstrumented posterolateral fusion in rabbits.
    Jenis LG; Wheeler D; Parazin SJ; Connolly RJ
    Spine J; 2002; 2(3):173-8. PubMed ID: 14589490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of local insulin application to lumbar spinal fusions in a rat model.
    Koerner JD; Yalamanchili P; Munoz W; Uko L; Chaudhary SB; Lin SS; Vives MJ
    Spine J; 2013 Jan; 13(1):22-31. PubMed ID: 23295034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
    Martin GJ; Boden SD; Titus L
    Spine (Phila Pa 1976); 1999 Nov; 24(21):2188-93; discussion 2193-4. PubMed ID: 10562982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study.
    Boden SD; Grob D; Damien C
    Spine (Phila Pa 1976); 2004 Mar; 29(5):504-14. PubMed ID: 15129063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
    Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
    World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
    Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
    Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine.
    Blattert TR; Delling G; Dalal PS; Toth CA; Balling H; Weckbach A
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2697-705. PubMed ID: 12461396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies.
    Johnsson R; Strömqvist B; Aspenberg P
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2654-61. PubMed ID: 12461391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.